Research Article
Analytical Method Development for Dorzolamide Using UV Spectroscopy
Author(s): Sachin Kothawade*, Shubhangi Albhar, Vijaykumar Wakale, Sandesh Bole, Kunal Raut, Prashant Patil, Jay prakash Suryawanshi, Payal Navasupe, Rachana Hajare, Sharmila Kuskar, Vaibhav Wagh and Vishal Pande
The development and evaluation of an analytical technique for the UV spectroscopy based determination of Dorzolamide is the main focus of this
study. Dorzolamide, a carbonic anhydrase inhibitor, is utilized to reduce intraocular pressure in the treatment of ocular hypertension and openangle
glaucoma. The study involved establishing the maximum wavelength (λmax) of Dorzolamide HCL as 253 nm, confirmed by UV spectra in
different media. The method's validation included linearity testing, where a calibration curve exhibited a strong correlation (R2=0.9995) in
simulated tear fluid. Accuracy studies demonstrated a high precision of 98%-100%, while precision tests, both intra-day and inter-day, indicated a
%RSD of less than 2%, confirming the method's reliability. The method's sensitivity was assessed with Limit of Detection (LOD) and Quantificatio.. Read More»
DOI:
10.4172/0975-413X.16.1.172-177
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report